Senior insider sale
EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.39M
4.91K shares
MCKECHNIE DUNCAN plans to sell 4.91K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
ESPP Purchase
Cash
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
ESPP Purchase
Cash
ESPP Purchase
Cash
ESPP Purchase
Cash
ESPP Purchase
Cash
ESPP Purchase
Cash
ESPP Purchase
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2025 | ESPP Purchase Cash | 46.00 | — |
2/26/2025 | Restricted Stock Vesting Compensation | 994.00 | — |
2/24/2025 | Restricted Stock Vesting Compensation | 331.00 | — |
2/17/2025 | Restricted Stock Vesting Compensation | 1.22K | — |
2/10/2025 | Restricted Stock Vesting Compensation | 2.02K | — |
11/14/2024 | ESPP Purchase Cash | 18.00 | — |
5/14/2024 | ESPP Purchase Cash | 52.00 | — |
11/14/2023 | ESPP Purchase Cash | 23.00 | — |
5/14/2023 | ESPP Purchase Cash | 59.00 | — |
11/14/2022 | ESPP Purchase Cash | 57.00 | — |
5/14/2022 | ESPP Purchase Cash | 89.00 | — |
| Total | 4.91K | ||
Units to sell
4.91K
Market value
$2.39M
Units
4.91K
Value
$2.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/25/2026 | 4.91K | $2.39M | NASDAQ | Planned |
| Total | 4.91K | $2.39M | ||